Hanson McClain Advisors »

Cortexyme shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.0k 1.5k 3.35
2023-09-30 $300 267 1.12
2023-06-30 $401 267 1.51
2023-03-31 $417 267 1.56

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Cortexyme

Nantahala Capital Management
Vanguard Group
Woodline Partners
Millennium Management
Ieq Capital
Almitas Capital
Superstring Capital Management
Stempoint Capital
Renaissance Technologies
Geode Capital Management
Jane Street
Marshall Wace
BlackRock
Susquehanna International
HighTower Advisors

View all funds holding Cortexyme